Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Thrombosis and Haemostasis

• Publication date

  1995-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/S-0038-1653860PMID 7482395
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of Storage Conditions on Activated Protein C Resistance Assay

  1995cited by this paper
• Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism.

  1995cited by this paper
• Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia.

  1994cited by this paper
• Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.

  1994cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994cited by this paper
• Frequency of a defective response to activated protein C in patients with a history of venous thrombosis.

  1994cited by this paper
• High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis

  1994cited by this paper
• Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.

  1994cited by this paper
• Resistance to activated protein C as a basis for venous thrombosis.

  1994cited by this paper
• Multicenter Evaluation of a Kit for Activated Protein C Resistance on Various Coagulation Instruments Using Plasmas from Healthy Individuals

  1994cited by this paper
• Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.

  1994cited by this paper
• Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.

  1994cited by this paper
• Laboratory Diagnosis of APC-Resistance: A Critical Evaluation of the Test and the Development of Diagnostic Criteria

  1994cited by this paper
• Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.

  1994cited by this paper
• Human genetics. Bad blood by mutation.

  1994cited by this paper
• The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects

  1994cited by this paper
• Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.

  1994cited by this paper
• Anticoagulant protein C pathway defective in majority of thrombophilic patients.

  1993cited by this paper
• Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

  1993cited by this paper
• Resistance to Activated Protein C in Nine Thrombophilic Families: Interference in a Protein S Functional Assay

  1993cited by this paper
• Inherited predisposition to thrombosis.

  1993cited by this paper
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

  1993cited by this paper
• Structure of the gene for human coagulation factor V.

  1992cited by this paper
• Thromboembolic Disease – Critical Evaluation of Laboratory Investigation

  1992cited by this paper
• Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis

  1991cited by this paper
• Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.

  1990cited by this paper
• Absence of thrombosis in subjects with heterozygous protein C deficiency.

  1987cited by this paper

• Prognostic effect of Factor V Leiden mutation in pregnant women with preeclampsia, eclampsia and chronic hypertension. Factor V Leiden mutation in prognosis of preeclampsia.

  2024cites this paper
• Regulation of factor V by the anticoagulant protease activated protein C: Influence of the B-domain and TFPIα

  2022cites this paper
• Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH

  2019cites this paper
• PULMONARY THROMBOEMBOLISM AND ROLE OF FACTOR V LEIDENIN ITS DEVELOPMENT-REVIEW OF LITERATURE

  2019cites this paper
• Inferior vena cava syndrome in neonates: An evidence‐based systematic review of the literature

  2019cites this paper
• Comparison of two methods for factor five Leiden detection in patients with thromboembolism

  2018cites this paper
• Factor V Leiden

  2016cites this paper
• Maximising the diagnostic potential of APTT‐based screening assays for activated protein C resistance

  2015cites this paper
• Hyperhomocysteinemia and C677T Polymorphism of MTHFR Gene in Patients with Venous Thromboembolism of the Algerian

  2015cites this paper
• Maternal plasma biomarkers for down syndrome: present and future.

  2013cites this paper
• Investigation of the interaction of multimerin 1 with components of prothrombinase, in vitro

  2012cites this paper
• Chapter 77 – Budd-Chiari syndrome and venoocclusive disease

  2012cites this paper
• Prevalence of thrombophilic mutations in patients with unprovoked thromboembolic disease. A comparative analysis regarding arterial and venous disease.

  2012cites this paper
• Aetiology of Venous Thrombosis

  2012influential citation
• Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals

  2011cites this paper
• Medical history screening for thrombophilic risk: is this adequate?

  2011cites this paper
• High Prevalence of Activated Protein C Resistance and Factor V Leiden Mutation in an Arab Population and Patients With Venous Thrombosis in Kuwait

  2010cites this paper
• Factor V Leiden mutation in Arabs in Kuwait by real-time PCR: different values for different Arabs

  2010cites this paper
• Factor V Leiden and Contraception

  2010cites this paper
• Regulation of the protein C anticoagulant and antiinflammatory pathways.

  2010cites this paper
• Laboratory evaluation of hypercoagulability.

  2009cites this paper
• Activated protein C resistance and factor V Leiden: a review.

  2007cites this paper
• Budd-Chiari Syndrome and Veno-occlusive Disease

  2007cites this paper
• Warfarin-induced Skin Necrosis and Venous Limb Gangrene: Lesson from a Case Induced the Serious Complications by the Anticoagulants During the Treatment of Acute Artery Occlusion

  2007cites this paper
• Mini-Gastric Bypass in a Patient Homozygous for Factor V Leiden

  2007cites this paper
• Anomalies constitutionnelles de la coagulation prédisposant à la thrombose

  2007cites this paper
• A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method

  2006cites this paper
• Influence of Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism, B Vitamins and Other Factors on Plasma Homocysteine and Risk of Thromboembolic Disease in Chinese

  2005cites this paper
• THE 2003 MARSHALL R. URIST AWARD PAPER: Genetic Background of Osteonecrosis: Associated with Thrombophilic Mutations?

  2004cites this paper
• Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C

  2004cites this paper
• Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.

  2004cites this paper
• Factor V Leiden and contraception.

  2004cites this paper
• The Predictability of Factor V Leiden (FV:Q506) Gene Mutation via Clotting-Based Diagnosis of Activated Protein C Resistance

  2004cites this paper
• Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors

  2004cites this paper
• Incidence of Factor V Leiden in Patients with Acute Myocardial Infarction

  2004cites this paper
• Search for Factor V Arg306 Cambridge and Hong Kong Mutations in Mixed Hungarian Population Samples

  2003cites this paper
• Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia.

  2003cites this paper
• Exosite-dependent regulation of the protein C anticoagulant pathway.

  2003cites this paper
• The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.

  2003cites this paper
• Resistance to Activated Protein C, Factor V Leiden and the Prothrombin G20210A Variant in Patients with Colorectal Cancer

  2002cites this paper
• A 9‐year retrospective assessment of laboratory testing for activated protein C resistance: evolution of a novel approach to thrombophilia investigations

  2002cites this paper
• Synergistic Effect of Thrombomodulin Promoter -33G/A Polymorphism and Smoking on the Onset of Acute Myocardial Infarction

  2002cites this paper
• The effect of factor V Leiden carriage on maternal and fetal health.

  2002cites this paper
• [Status of hereditary hypercoagulability and cerebral venous thrombosis. Report of 3 cases].

  2002cites this paper
• Obstetric implications of the factor V leiden mutation: a review.

  2002cites this paper
• Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm.

  2002cites this paper
• Mutations et polymorphismes génétiques associés aux thromboses

  2001cites this paper
• Simultaneous Bilateral Upper Extremity Venous Thrombosis in a Factor V Leiden Heterozygote

  2001cites this paper
• G20210A prothrombin gene mutation identified in patients with venous leg ulcers

  2001cites this paper
• Is Factor V Leiden Associated with an Increased Risk for Fetal Loss

  2001cites this paper
• The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance

  2001cites this paper
• Correlation between activated protein C-resistance and factor V Leiden mutation

  2001cites this paper
• Stroke in young adults and children

  2001cites this paper
• Combined factor V Leiden and prothrombin genotyping in patients presenting with thromboembolic episodes.

  2001cites this paper
• Activated protein C resistance in patients with arterial ischemic stroke.

  2001cites this paper
• Resistance to activated protein C and FV leiden mutation in patients with a history of acute myocardial infarction or primary hypertension.

  2000cites this paper
• Causes of venous thrombosis in fifty Chinese patients

  2000cites this paper
• The influence of age, sex, vitamin B(12), folate levels and methylenetetrahydrofolate reductase C677T genetic mutations on plasma homocysteine in the Chinese population.

  2000cites this paper
• Activated Protein C Resistance: The Most Common Risk Factor for Venous Thromboembolism

  2000cites this paper
• Factor V Leiden genotyping using real-time fluorescent polymerase chain reaction.

  2000cites this paper
• Prevalence of prothrombin 20210A allele and methylenetetrahydrofolate reductase C677T genetic mutations in the Chinese population

  2000cites this paper
• [Pulmonary embolism in the child: diagnostic and therapeutic particularities].

  2000cites this paper
• Method-dependent influence of certain polymorphisms in the factor V B-domain on the response to activated protein C

  2000cites this paper
• Risk of Thrombosis in Patients Homozygous and Heterozygous for Factor V Leiden in the East Bohemian Region

  2000cites this paper
• Génotypage du facteur V Leiden: résultats obtenus sur plus de 5 000 échantillons cliniques

  2000cites this paper
• Neue Aspekte in der Diagnostik und Klinik hereditärer Thrombophilien. New Aspects in the Diagnostics and Clinical Picture of Hereditary Thrombophilia

  2000cites this paper
• Factor V Leiden genotyping using real-time fluorescent polymerase chain reaction.

  2000cites this paper
• Activated Protein C Resistance and Thrombosis: Molecular Mechanisms of Hypercoagulable State Due to FVR506Q Mutation

  1999cites this paper
• Activated protein C resistance in young African American patients with ischemic stroke.

  1999cites this paper
• Use of Transgenic Mice in the Study of Thrombosis and Hemostasis

  1999cites this paper
• [Migrainous infarct in pregnancy].

  1999cites this paper
• The investigation and management of inherited thrombophilia.

  1999cites this paper
• Activated Protein C Resistance (FV:Q506) and Pregnancy

  1999cites this paper
• Allelic Discrimination of Factor V Leiden Using a 5’ Nuclease Assay

  1999cites this paper
• Prevalence of Factor V Leiden in Patients with Myocardial Infarction and Normal Coronary Angiography

  1999cites this paper
• Is factor V Leiden a risk factor for fetal loss?

  1999cites this paper
• Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.

  1999cites this paper
• Double Fluorescent-amplification Refractory Mutation Detection (dF-ARMS) of the Factor V Leiden and Prothrombin Mutations

  1999cites this paper
• Platelet-dependent and procoagulant mechanisms in arterial thrombosis.

  1999cites this paper
• Current concepts of coagulation and fibrinolysis.

  1998cites this paper
• Détection directe par PCR de la mutation du facteur V Leiden: analyse routinière sur plus de 1 000 échantillons cliniques

  1998cites this paper
• Factor V Leiden and the risk of proximal venous thrombosis after total hip arthroplasty.

  1998cites this paper
• Deep Venous Thrombosis Prophylaxis

  1998cites this paper
• Should we screen for factor V Leiden?

  1998cites this paper
• Multiple hemostatic abnormalities in young adults with activated protein C resistance and cerebral ischemia.

  1998cites this paper
• [Prothrombotic states and cerebral ischemia].

  1998cites this paper
• Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale.

  1998cites this paper
• Standardization of the APC Resistance Test. Effects of Normalization of Results by Means of Pooled Normal Plasma

  1998cites this paper
• Laboratory evaluation of hypercoagulable states.

  1998cites this paper
• Assessment of activated protein C resistance using a new and rapid venom-based test: STA Staclot APC-R.

  1998cites this paper
• Activated protein C resistance and the factor V Leiden mutation in children with thrombosis

  1998cites this paper
• Sensitivity, Specificity and Predictive Value of Modified Assays for Activated Protein C Resistance in Children

  1998cites this paper
• Inherited Thrombophilia due to Factor V Leiden Mutation.

  1998cites this paper
• Factor V Leiden: pathophysiology and clinical implications

  1998cites this paper
• The role of activated protein C resistance in the pathogenesis of venous thrombosis.

  1998cites this paper
• Prevalence of APC-Resistance in the East Bohemian Region

  1998cites this paper
• Cross-linking hybridization assay for direct detection of factor V Leiden mutation.

  1997cites this paper
• Preeclampsia is associated with a reduced response to activated protein C.

  1997cites this paper
• APC resistance and factor V Leiden (FV:Q506) mutation in patients with ischemic cerebral events. Vienna Thrombophilia in Stroke Study Group (VITISS)

  1997cites this paper
• Clinical Features in 36 Patients Homozygous for the ARG 506 → GLN Factor V Mutation

  1997cites this paper